ZYMUTEST HIA IgG, in vitro diagnostic ELISA kit, Ref. RK040A Recall
ZYMUTEST HIA IgG, in vitro diagnostic ELISA kit, Ref. RK040A
FDA recall Class II
Ongoing
FDA lists this Class II recall for ZYMUTEST HIA IgG, in vitro diagnostic ELISA kit, Ref. RK040A. Review the affected identifiers, reported reason and manufacturer instructions below.
Recall at a glance
- Recall number
- Z-2171-2026
- Recall classification
- Class II
- Enforcement status
- Ongoing
- Initiation date
- Apr 1, 2026
- FDA report date
- May 20, 2026
- Quantity in commerce
- 359 units
- Distribution
- See key details
- FDA cause
- Labeling Change Control
What is being recalled?
ZYMUTEST HIA IgG, in vitro diagnostic ELISA kit, Ref. RK040A
Affected model & UDI checker
Search the exact identifiers published for Z-2171-2026.
The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.
Affected products
| Model / catalog number | Product | Lot scope reported | UDI / GTIN |
|---|---|---|---|
| RK040A | ZYMUTEST HIA IgG, in vitro diagnostic ELISA kit, Ref. RK040A | Check source notice | Not specified |
| Not specified | ZYMUTEST HIA IgG, in vitro diagnostic ELISA kit, Ref. RK040A | Check source notice | 03663537018763 |
FDA code information
UDI-DI: 03663537018763; Lot Number: FD1265
Why was this product recalled?
Kits from lot FD1265 had been packaged on 17 October 2024 and put on the market with an outdated flyer (8 October 2024), containing incorrect values for the positive control.
What actions did Aniara Diagnostica LLC take?
A Field Corrective Action notification letter dated 3/30/26 was sent to customers. Actions implemented by HYPHEN BioMed: -Confirmation of the existence of a flyer discrepancy affecting 95 kits from lot FD1265. - Request for quarantine of the affected kits in US agent warehouse. -Coordination with US agent for notification of the impacted end users. -investigation to define the root cause and to establish corrective and preventive actions. Actions to be implemented by the end user: 1. Check the TAV flyer included in their kit. - If the flyer matches the correct version (dated 18 October 2024) - No action is required. - If the flyer corresponds to the incorrect version (dated I October 2024) - proceed to step 2 2. Destroy the incorrect TAV flyer. The outdated flyer included in the kit must be immediately removed and destroyed, as well as any paper or electronic copy that could have been done in end-user facility, to prevent further use. 3. Replace the incorrect flyer with the corrected version. Use the corrected TAV flyer provided with this notice for all future testing 4. Return the completed and signed form to your local distributor before April 15th, 2026. For any question or information regarding this notification, please contact vigilance team, by email at VigilanceHBM@hyphen-biomed.com.
Read the manufacturer action recorded by FDARecall timeline
Recall initiated by firm
FDA notice posted
FDA classification recorded
FDA enforcement report date
Related FDA submissions
No submission number with an exact verified relationship is linked in the retrieved recall notice.
FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.
Source and update history
- FDA recall notice Z-2171-2026
- openFDA enforcement record · Source release Nov 11, 2026 · Retrieved Nov 21, 2026
- openFDA device recall record · Source release Nov 19, 2026 · Retrieved Nov 21, 2026
- FDA enforcement data
First stored snapshot of this source.
- FDA device-recall notice
First stored snapshot of this source.
The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.
Our data sources and methodology